Journal of neurology, neurosurgery, and psychiatry · 2013
Transcranial magnetic stimulation as an efficient treatment for psychogenic movement disorders.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Garcin Béatrice, Roze Emmanuel, Mesrati Francine, Cognat Emmanuel, Fournier Emmanuel, Vidailhet Marie, Degos Bertrand
Аннотация
BACKGROUND: Management of psychogenic movement disorders (PMDs) is challenging for neurologists and, to date, there is no consensus about their treatment. Recent studies suggested a possible therapeutic effect of repeated transcranial magnetic stimulation (TMS) in psychogenic paralysis and tremor.
OBJECTIVE: To document the clinical impact of TMS in PMDs.
METHODS: We blindly video scored symptoms of consecutive patients with PMD who were recorded before and after TMS. TMS was delivered at low frequency (0.25 Hz) over the motor cortex contralateral to symptoms.
RESULTS: Twenty-four patients were included. They presented with dystonia, myoclonus, tremor, Parkinsonism or stereotypies. The median duration of symptoms before TMS was 2.8 years (6 months to 30 years). The overall score of 75% of patients improved by >50% and, furthermore, the clinical benefits were sustained upon protracted follow-up (median 19.8 months). There was no correlation between improvement and duration of symptoms before TMS.
CONCLUSIONS: TMS is a therapeutic option for PMDs, including chronic PMDs.
OBJECTIVE: To document the clinical impact of TMS in PMDs.
METHODS: We blindly video scored symptoms of consecutive patients with PMD who were recorded before and after TMS. TMS was delivered at low frequency (0.25 Hz) over the motor cortex contralateral to symptoms.
RESULTS: Twenty-four patients were included. They presented with dystonia, myoclonus, tremor, Parkinsonism or stereotypies. The median duration of symptoms before TMS was 2.8 years (6 months to 30 years). The overall score of 75% of patients improved by >50% and, furthermore, the clinical benefits were sustained upon protracted follow-up (median 19.8 months). There was no correlation between improvement and duration of symptoms before TMS.
CONCLUSIONS: TMS is a therapeutic option for PMDs, including chronic PMDs.
Предметные рубрики MeSH
AdultAgedConversion DisorderDystoniaElectroencephalographyEvoked Potentials, MotorEvoked Potentials, SomatosensoryFemaleHumansMaleMental DisordersMiddle AgedMovement DisordersMyoclonusParkinsonian DisordersPilot ProjectsProspective StudiesRecurrenceTranscranial Magnetic StimulationTreatment OutcomeTremorYoung Adult